21 “...) treatment for Prader-Willi syndrome (PWS) in adolescent and adult patients and the evidence based guidelines...”

22

23

24 “... for the treatment of severe vernal keratoconjunctivitis (VKC) in children from four years of age through adolescence...”

25 Subjects: “...Adolescent...”

26 “...-effectiveness of QMF among adolescents is uncertain as the sponsor's analysis reflects a predominately adult...”

27 Subjects: “...Adolescent...”

28 Subjects: “...Adolescent...”

29 “...) be reimbursed as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years...”

30 “...) be reimbursed as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years...”

31 “...-specific. In adolescents 12 to 17 years old who weigh < 60 kg, two subcutaneous injections of 200 mg of DUP...”

32 “... corneal deposits appears in about 50% of patients from mid-childhood to adolescence. Juvenile...”

33 “... hyperactivity disorder (ADHD) in children, adolescents, and adults from current evidence-based clinical...”

34 “... complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older...”

35 “... Organization (WHO), among adolescents, overweight is defined as one standard deviation above the mean BMI...”

36 “... Organization (WHO), among adolescents, overweight is defined as one standard deviation above the mean BMI...”

37 “... and high doses of atypical antipsychotic agents for adolescents and adults with schizophrenia, in public...”

38 “... and high doses of atypical antipsychotic agents for adolescents and adults with schizophrenia, in public...”

39 “... that are relevant to the Canadian context on the neurological or cognitive development in children and adolescents...”

40 “... and cost-effectiveness of GXR for the treatment children and adolescents with ADHD. Clinical guidelines...”